Dosimetry of high-dose treatment with 131I in differentiated thyroid cancer -: Evaluation by PET and 124I.

被引：0
|
作者：
Eschmann, SM
Thelen, MH
Reischl, G
Zagar, I
Dohmen, BM
Coenen, HH
Machulla, HJ
Bares, R
机构：
[1] Res Ctr Julich, Julich, Germany
[2] Univ Belgrade, Belgrade, Yugoslavia
[3] Univ Tubingen, Tubingen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
333
引用
收藏
页码：84P / 84P
页数：1
相关论文
共 50 条
  • [31] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [32] Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer
    Jentzen, Walter
    Freudenberg, Lutz
    Eising, Emst G.
    Sormenschein, Wilfried
    Knust, Jochen
    Bockisch, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (06) : 1017 - 1023
  • [33] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [34] Low-dose and high-dose 131I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
    瞿源
    China Medical Abstracts(Internal Medicine), 2017, 34 (01) : 20 - 21
  • [35] Ablative treatment with 131I in low-risk papillary thyroid cancer: is low-dose as effective as high-dose?
    Unceta Barrenechea, A. Roteta
    Andres Gracia, A.
    Tardin Cardoso, L.
    Saker Diffalah, Y.
    Razola Alba, P.
    Escalera Temprado, T.
    Delgado Castro, M.
    Prats Rivera, E.
    Abos Olivares, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S362 - S363
  • [36] Radiodine uptake in thyroid remnants in patients with differentiated thyroid cancer:: A comparison between very-low 131I diagnostic dose and high 131I therapy activities
    Azevedo-Silva, F.
    Cavaco, A.
    Freitas, D.
    Isidoro, J.
    Vieira, F.
    Costa, G.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S230 - S230
  • [37] The evolving role of 131I for the treatment of differentiated thyroid carcinoma
    Robbins, RJ
    Schlumberger, MJ
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 : 28S - 37S
  • [38] Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer
    Karls, Shawn
    Abikhzer, Gad
    Tamilia, Michael
    Probst, Stephan
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 247 - 249
  • [39] Prescribed Activity of 131I Therapy in Differentiated Thyroid Cancer
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 697 - 699
  • [40] 131I Dosimetry and thyroid stunning -: Reply
    Gulec, SA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (12) : 2040 - 2040
12345